Neuroimmunomodulatory properties of laquinimod
Laquinimod (ABR-215062) is a quinolone-3-carboxamide derivative, which is an orally active immunostimulatory drug molecule and is being developed for multiple sclerosis cases like relapsing-remitting multiple sclerosis (RRMS) and chronic progressive multiple sclerosis (CPMS). Laquinimod may mediate...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Brain Disorders |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666459324000040 |